{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:22:06Z","timestamp":1793650926513,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.medj.2025.100725","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:42:24Z","timestamp":1749206544000},"page":"100725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Felix","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Zaczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Santos de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kohut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Auernig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Boehlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100725_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review","volume":"140","author":"Van Elk","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.medj.2025.100725_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.medj.2025.100725_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/0269881116679368","article-title":"Psychedelics in the treatment of unipolar mood disorders: A systematic review","volume":"30","author":"Rucker","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.medj.2025.100725_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100725_bib5","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.medj.2025.100725_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.medj.2025.100725_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.medj.2025.100725_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic Acid Diethylamide\u2013Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1192\/bjp.2024.99","article-title":"LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up","volume":"225","author":"Holze","year":"2024","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.medj.2025.100725_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/02698811231224171","article-title":"What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review","volume":"38","author":"Niarchou","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.medj.2025.100725_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2025.100725_bib14","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (2023). Psychedelic Drugs: Considerations for Clinical Investigations Guidance for Industry. https:\/\/www.fda.gov\/media\/169694\/download."},{"key":"10.1016\/j.medj.2025.100725_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-Dose Psilocybin Treatment for Major Depressive Disorder","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100725_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114297","article-title":"A systematic review and meta-analysis of the success of blinding in antidepressant RCTs","volume":"307","author":"Scott","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.medj.2025.100725_bib18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.medj.2025.100725_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.pra.0000462604.79606.4e","article-title":"Disagreement between therapist raters and independent evaluators in a controlled clinical trial of interpersonal psychotherapy for depressed pregnant women","volume":"21","author":"Spinelli","year":"2015","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.medj.2025.100725_bib20","unstructured":"von Zerssen, D., and Koeller, D.-M. (1976). Die Beschwerden-Liste. Preprint."},{"key":"10.1016\/j.medj.2025.100725_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.medj.2025.100725_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mpr.226","article-title":"The Inventory of Depressive Symptomatology: German translation and psychometric validation","volume":"16","author":"Drieling","year":"2007","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.medj.2025.100725_bib23","series-title":"BDI II: Beck Depressions-Inventar: Revision","author":"Hautzinger","year":"2006"},{"key":"10.1016\/j.medj.2025.100725_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.128.3.280","article-title":"The SCL-90 and the MMPI: a step in the validation of a new self-report scale","volume":"128","author":"Derogatis","year":"1976","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.medj.2025.100725_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1008931926181","article-title":"The Symptom Check-List-90-R (SCL-90-R): a German validation study","volume":"9","author":"Schmitz","year":"2000","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.medj.2025.100725_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100725_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000012333","article-title":"Measuring psychotherapeutic change with the Symptom Checklist SCL 90 R","volume":"68","author":"Schauenburg","year":"1999","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.medj.2025.100725_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2011.12.003","article-title":"Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes","volume":"138","author":"Reeves","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.medj.2025.100725_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0893-133X(95)00145-4","article-title":"Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans","volume":"14","author":"Bonson","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.medj.2025.100725_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0528.2009.00494.x","article-title":"Towards a proposal for assessment of blinding success in clinical trials: up-to-date review","volume":"37","author":"Kolahi","year":"2009","journal-title":"Community Dent. Oral Epidemiol."},{"key":"10.1016\/j.medj.2025.100725_bib32","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.medj.2025.100725_bib33","unstructured":"SAS Institute Inc. (2013). SAS\/ACCESS\u00ae 9.4 Interface to ADABAS: Reference."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:01:10Z","timestamp":1762639270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666634025001527"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100725","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100725"}}